Artwork

Content provided by Joe Chaffin, MD, Joe Chaffin, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joe Chaffin, MD, Joe Chaffin, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

070CE: Preventing Alloantibodies in Sickle Cell Disease with Stella Chou

56:17
 
Share
 

Manage episode 235408894 series 2390656
Content provided by Joe Chaffin, MD, Joe Chaffin, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joe Chaffin, MD, Joe Chaffin, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Alloimmunization after red blood cell (RBC) transfusion is a huge challenge in the treatment of sickle cell disease (SCD). Even when donors and patients are "matched," anti-Rh antibodies in patients with sickle cell disease are formed way often than we would like or expect. Further, Dr. Stella Chou has shown that nearly a third of patients with those new antibodies actually have hemolytic transfusion reactions! It's a huge problem.

In this interview, Dr. Chou, a pediatric hematologist from Philadelphia, shows that the problem comes in part from widespread genetic RH variations in both Black blood donors and patients with sickle cell disease. She models a future direction that may help us finally solve this problem once and for all: Genotype matching of donors and patients!

NOTE: CE credit has expired for this episode.

  continue reading

105 episodes

Artwork
iconShare
 
Manage episode 235408894 series 2390656
Content provided by Joe Chaffin, MD, Joe Chaffin, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joe Chaffin, MD, Joe Chaffin, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Alloimmunization after red blood cell (RBC) transfusion is a huge challenge in the treatment of sickle cell disease (SCD). Even when donors and patients are "matched," anti-Rh antibodies in patients with sickle cell disease are formed way often than we would like or expect. Further, Dr. Stella Chou has shown that nearly a third of patients with those new antibodies actually have hemolytic transfusion reactions! It's a huge problem.

In this interview, Dr. Chou, a pediatric hematologist from Philadelphia, shows that the problem comes in part from widespread genetic RH variations in both Black blood donors and patients with sickle cell disease. She models a future direction that may help us finally solve this problem once and for all: Genotype matching of donors and patients!

NOTE: CE credit has expired for this episode.

  continue reading

105 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide